Results 111 to 120 of about 805 (190)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy. [PDF]

Prz Menopauzalny, 2023
Douxfils J, Foidart JM, Gaspard U, Chatel G, Taziaux M, Jost M, Gérard C, Morimont L.   +7 more
europepmc   +1 more source

Editorial: Recent advances in thromboembolism and oral contraceptives. [PDF]

Front Endocrinol (Lausanne)
Morimont L, Foidart JM.
europepmc   +1 more source

Menopausal Hormone Therapy-Risks, Benefits and Emerging Options: A Narrative Review. [PDF]

Int J Mol Sci
Arnautu AM, Nimigean VR, Nacea-Radu CA, Tilici DM, Paun DL.   +4 more
europepmc   +1 more source

Regulation of Human Renal Transporters by Pregnancy-Related Hormones in Primary Proximal Tubular Epithelial Cells. [PDF]

Metabolites
Tsang YP, Wang K, Kelly EJ, Mao Q, Unadkat JD.   +4 more
europepmc   +1 more source

Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms. [PDF]

Drugs
Young Moss S, Lee A, Simon JA.
europepmc   +1 more source

Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea. [PDF]

Med Sci Monit
Wójcikiewicz P, Durlej G, Satora M, Tarkowski R, Kułak K.   +4 more
europepmc   +1 more source

Arterial Hypertension and its Impact on the Prescription of Combined Hormonal Contraception. [PDF]

Mater Sociomed
Legan M, Dezman LV, Kokol NL, Mlinaric M.   +3 more
europepmc   +1 more source

Estetrol and breast cancer

, 2022
openaire   +1 more source

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61". [PDF]

Pharmaceuticals (Basel)
Tassi A, Londero AP, Xholli A, Lanzolla G, Bertozzi S, Savelli L, Prefumo F, Cagnacci A.   +7 more
europepmc   +1 more source

Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1. [PDF]

J Clin Med
Coelingh Bennink HJT, Roos EPM, van Moorselaar RJA, van Melick HHE, Somford DM, Roeleveld TA, de Haan TD, Reisman Y, Schultz IJ, Krijgh J, Debruyne FMJ.   +10 more
europepmc   +1 more source